Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04010747 · ClinicalTrials.gov registry record · NA

Pilot Study of Motivational Interviewing for Loved Ones

A NA study, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
71
Enrollment target

NCT04010747: Completed NA study, sponsored by Boston Medical Center.

NCT04010747 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04010747, a NA study, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target

Study Summary

The study population for this research will include parents and concerned significant others (PCSO) of individuals experiencing recent (past five years) onset of a psychotic disorder (hereafter referred to as individuals with psychosis, "IP") who are not currently engaged with, or at risk for disengagement from, treatment. MILO is a brief and structured intervention that teaches motivational interviewing communication strategies. The initial aim (phase 1) of this pilot study is to evaluate feasibility of the intervention. The secondary aims are to evaluate the effectiveness of MILO for (1) enhancing the engagement of IP with evidence-based treatments and (2) reducing distress among PCSO. The investigators hypothesize that the intervention will be superior to control condition for both enhancing IP engagement with mental health services and reducing PCSO distress.

Primary Outcome

The participant will report the number of mental health related appointments attended by the IP during the past month via a structured survey.

Interventions

  • BEHAVIORAL Motivational Interviewing for Loved Ones (MILO)
  • BEHAVIORAL Mental Health Services Consultation and Waitlist

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2020-03-01
Est. Completion 2022-04-30
Phase NA
Boston Medical Center

253 total trials

What the finished NCT04010747 record still lists

NCT04010747 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Motivational Interviewing for Loved Ones (MILO) is the first listed.

NCT04010747 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04010747 about?

NCT04010747 is a clinical study titled "Pilot Study of Motivational Interviewing for Loved Ones". The study population for this research will include parents and concerned significant others (PCSO) of individuals experiencing recent (past five years) onset of a psychotic disorder (hereafter referred to as individuals with psychosis, "IP") who are not currently engaged with, or at risk for diseng...

What is the current status of trial NCT04010747?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2020-03-01. Estimated completion is 2022-04-30.

What interventions are being tested in trial NCT04010747?

The interventions under investigation include: Motivational Interviewing for Loved Ones (MILO) (BEHAVIORAL), Mental Health Services Consultation and Waitlist (BEHAVIORAL).

Who is sponsoring clinical trial NCT04010747?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04010747's enrollment target sits among peer trials

71 1102nd of 2000 higher than 898 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05452889 · 71 participants · Early Phase 1

    PET Image in PAH Patients

  • NCT05766943 · 71 participants · NA

    Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

  • NCT06229678 · 71 participants · Early Phase 1

    Ketones, SGLT2, HFrEF

  • NCT06377566 · 71 participants · Phase 2

    A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04010747, the US trial registry maintained by the National Library of Medicine. NCT04010747 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.